Single Injection of REGN475/SAR164877 in Treatment of Vertebral Fracture Pain

NCT01001715 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision due to low subject recruitment and enrollment

Conditions

Back Pain

Interventions

DRUG: REGN475/SAR164877
DRUG: Placebo (for REGN475/SAR164877)

Sponsor

Regeneron Pharmaceuticals